Legal status · Australia
Is Amycretin legal in Australia?
No. Amycretin is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Amycretin in Australia at a glance
| Classification | Investigational, not registered |
|---|---|
| TGA approval status | Not approved by TGA; investigational |
| Evidence level | Moderate (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Amycretin profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
Amycretin is being studied in registered clinical trials but has not received TGA marketing approval in Australia.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Amycretin is
Novo Nordisk's single-molecule GLP-1 and amylin agonist, in oral and injectable forms, that showed strong early weight loss and is heading to Phase 3.
Amycretin is a Novo Nordisk drug that combines GLP-1 and amylin activity in a single molecule, aiming to match combination therapy in one agent. It is being developed in both oral and injectable forms.
Mechanism: A single molecule that agonizes both the GLP-1 and amylin receptors to suppress appetite through two complementary pathways.
Regulatory history: Investigational (Phase 3 AMAZE program started February 2026)
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Amycretin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Amycretin in other countries
Frequently asked questions
Is Amycretin legal in Australia?
No. Amycretin is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Can I buy Amycretin in Australia?
No approved product exists to buy. In Australia Amycretin is classified as "Investigational, not registered", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Amycretin TGA approved?
No. In Australia Amycretin is classified as "Investigational, not registered", which is not a TGA marketing approval. For comparison, the US FDA status is: Investigational (Phase 3 AMAZE program started February 2026). Evidence level: Moderate.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Amycretin live on its compound profile.
Amycretin profileThis page is general information about the regulatory status of Amycretin in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.